Skip to main content

Key Product Details

Species Reactivity

Validated:

Human, Mouse

Cited:

Human, Primate - Macaca fascicularis (Crab-eating Monkey or Cynomolgus Macaque)

Applications

Validated:

Intracellular Staining by Flow Cytometry

Cited:

Flow Cytometry

Label

Phycoerythrin (Excitation = 488 nm, Emission = 565-605 nm)

Antibody Source

Monoclonal Mouse IgG2A Clone # 245610

Product Specifications

Immunogen

E. coli-derived recombinant human SOX2
Gly135-Met317
Accession # P48431

Specificity

Detects human and mouse SOX2 in Western blots.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2A

Scientific Data Images for Human/Mouse SOX2 PE-conjugated Antibody

Detection of SOX2 antibody in NTera-2 Human Cell Line antibody by Flow Cytometry.

Detection of SOX2 in NTera-2 Human Cell Line by Flow Cytometry.

NTera-2 human testicular embryonic carcinoma cell line was stained with Mouse Anti-Human/Mouse SOX2 PE-conjugated Monoclonal Antibody (Catalog # IC2018P, filled histogram) or isotype control antibody (Catalog # IC003P, open histogram). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (Catalog # FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (Catalog # FC005). View our protocol for Staining Intracellular Molecules.
Detection of Human SOX2 by Flow Cytometry

Detection of Human SOX2 by Flow Cytometry

(a) RT-PCR analysis of SOX2 expression normalized to GAPDH in human tissues. BM from MM patients (n = 25), healthy donors (n = 15), myeloma cell lines (n = 10), and 20 human tissues (n = 1) was screened for SOX2 expression. Aqua dest. and non-reverse-transcribed mRNA were used as negative controls. 20 organs were tested for the presence of contaminating DNA. The resulting copy numbers (reverse-transcriptase-free) were normalized to GAPDH copy number of the respective tissue (cDNA). The mean value of all reverse-transcriptase-free results was calculated and included as the reverse-transcriptase-free (RT-free) condition. (b) FACS analysis of three MM patients' BM, three BM of healthy donors, and three peripheral blood samples of healthy donors for SOX2 expression in gated CD138+ plasma cells. One BM sample (3) was found negative for SO2 protein expression. SOX2 expression was also found in 10 different myeloma cell lines. Isotype antibodies served as negative control for SOX2 expression. (c) Correlation analysis of SOX2 expression and percentage of plasma cells in the BM of MM patients. No significant association between SOX2 expression and the amount of plasma cells was found (P = 0.6018, r2 = 0.03556). HD: healthy donor; MM: multiple myeloma; BM: bone marrow; PB: peripheral blood. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/22190969), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Monkey SOX2 by Flow Cytometry

Detection of Monkey SOX2 by Flow Cytometry

Pluripotency of Monkey ESCs grown under the MT-fCFA culture condition.A. Immunocytochemical analyses show that CMK6SFF cells (P33) have a characteristic expression pattern of typical pluripotency factors, Nanog, Oct4, and Sox2 as well as that of cell surface markers, SSEA-4, TRA-1-60, and TRA-1-81, indicating their undifferentiated and pluripotent state. Scale bar = 100 µm. B. Flow cytometric analysis of Nanog, Oct4, and Sox2 co-expressing CMK6SFF cells (P35) under the MT-fCFA culture condition. Cells were co-stained with Alexa Fluor 647-conjugated anti-Nanog, Alexa Fluor 488-conjugated anti-Oct4, and PE-conjugated anti-Sox2 or the corresponding isotype controls. C. CMK6SFF (P37) and CMK970 (P31) cells are positive for alkaline phosphatase activity. ALP, alkaline phosphatase. Scale bar = 100 µm. Image collected and cropped by CiteAb from the following publication (https://dx.plos.org/10.1371/journal.pone.0088346), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human/Mouse SOX2 PE-conjugated Antibody

Application
Recommended Usage

Intracellular Staining by Flow Cytometry

10 µL/106 cells
Sample: NTera‑2 human testicular embryonic carcinoma cell line fixed with Flow Cytometry Fixation Buffer (Catalog # FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (Catalog # FC005)
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Formulation

Supplied in a saline solution containing BSA and Sodium Azide.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Protect from light. Do not freeze.
  • 12 months from date of receipt, 2 to 8 °C as supplied.

Background: SOX2

SOX2 belongs to the SOX (SRY-like HMG box) family of transcription factors with diverse roles in development. SOX2 functions in specifying the first three lineages present at implantation and in regulating proliferation and differentiation in the developing peripheral nervous system (1-6).

References

  1. Graham, V. et al. (2003) Neuron 39:749.
  2. Avilion, A.A. et al. (2003) Genes Dev. 17:126.
  3. Kishi, M. et al. (2000) Development 127:791.
  4. Yuan, H. et al. (1995) Genes Dev. 9:2635.
  5. Uwanogho, D. et al. (1995) Mech. Dev. 49:23.
  6. Stevanovic, M. (2003) Mol. Biol. Rep. 30:127.

Long Name

Transcription Factor SOX2

Alternate Names

ANOP3, MCOPS3, MGC2413, SRY (sex determining region Y)-box 2, SRY-related HMG-box gene 2, transcription factor SOX2, transcription factor SOX-2

Entrez Gene IDs

6657 (Human)

Gene Symbol

SOX2

UniProt

Additional SOX2 Products

Product Documents for Human/Mouse SOX2 PE-conjugated Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human/Mouse SOX2 PE-conjugated Antibody

For research use only

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...